Biechele Royce Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$17.1M Sell
271,413
-2,933
-1% -$184K 5.63% 6
2024
Q2
$16.2M Buy
274,346
+71,546
+35% +$4.23M 5.47% 5
2024
Q1
$16.2M Buy
202,800
+3,513
+2% +$280K 5.36% 5
2023
Q4
$15.7M Buy
199,287
+7,018
+4% +$554K 5.15% 6
2023
Q3
$13.4M Buy
192,269
+6,232
+3% +$435K 4.95% 6
2023
Q2
$12.9M Buy
186,037
+25,508
+16% +$1.76M 4.48% 9
2023
Q1
$11.9M Buy
160,529
+11,864
+8% +$882K 4.44% 8
2022
Q4
$13.9M Buy
148,665
+1,168
+0.8% +$109K 5.65% 4
2022
Q3
$14.1M Sell
147,497
-1,405
-0.9% -$134K 6.62% 2
2022
Q2
$13.8M Sell
148,902
-309
-0.2% -$28.6K 6.13% 3
2022
Q1
$15.1M Sell
149,211
-2,956
-2% -$299K 6.02% 3
2021
Q4
$15.7M Buy
152,167
+789
+0.5% +$81.4K 6.28% 3
2021
Q3
$12.8M Buy
151,378
+10,414
+7% +$884K 5.68% 3
2021
Q2
$11.8M Buy
140,964
+7,693
+6% +$642K 5.09% 4
2021
Q1
$10M Buy
133,271
+2,017
+2% +$152K 5.05% 5
2020
Q4
$8.97M Buy
131,254
+2,907
+2% +$199K 5.05% 6
2020
Q3
$7.5M Sell
128,347
-3,900
-3% -$228K 4.71% 8
2020
Q2
$8.59M Sell
132,247
-1,445
-1% -$93.9K 5.42% 5
2020
Q1
$7.93M Sell
133,692
-1,137
-0.8% -$67.5K 6.1% 3
2019
Q4
$10M Sell
134,829
-3,533
-3% -$262K 6.02% 5
2019
Q3
$8.73M Sell
138,362
-10,924
-7% -$689K 5.77% 4
2019
Q2
$8.14M Buy
149,286
+32,379
+28% +$1.76M 5.37% 6
2019
Q1
$6.31M Buy
116,907
+6,520
+6% +$352K 4.08% 9
2018
Q4
$7.23M Buy
110,387
+3,365
+3% +$220K 5.2% 4
2018
Q3
$8.43M Sell
107,022
-249
-0.2% -$19.6K 5.27% 4
2018
Q2
$6.9M Buy
107,271
+17,362
+19% +$1.12M 4.63% 3
2018
Q1
$5.59M Buy
89,909
+3,903
+5% +$243K 3.9% 9
2017
Q4
$6.24M Buy
+86,006
New +$6.24M 4.24% 7